RESULTS

Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells (PNAS, 2019).

Tomonaga and Gotoh at Kanazawa University published the novel discovery of Semaphorin signaling in the study of breast cancer stem cells, as a collaboration.